The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapies
Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapy
Human Adipose-Derived Stem Cells Genetically Programmed to Induce Necroptosis for Cancer Immunotherapy
The arming of NK cells with Fc-engineered rituximab confers them specificity against CD20-expressing cells
Phthalocyanine Aggregates as “Semiconductor-like” Photocatalysts for Hypoxic-Tumor Photodynamic Immunotherapy
Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma
Pulmonary Engraftment Syndrome: A unique complication of allogeneic hematopoietic cell transplantation for myelofibrosis
Adoptive transfer of T lymphocytes retrovirally transduced to express personalized neoantigen reactive T cell receptors can mediate tumor regression in patients with metastatic colorectal cancer
The First Case of Multiple Myeloma Treated With ASCT followed by Anti-BCMA CART Cells using Retroviral Vector
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients